METHODS FOR DETECTING ENHANCED RISK OF OPIOID-INDUCED HYPOXIA IN A PATIENT

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120283283A1
SERIAL NO

13464025

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods for detecting enhanced risk of opioid-induced respiratory dysfunction in patients with normal levels of oxygen saturation. The method may comprise: (1) assaying blood of the patient for a normal level of oxygen saturation; (2) measuring the patient's respiration rate at rest for a normal rate; and (3) correlating the normal level of oxygen saturation and the normal rate of respiration with enhanced risk of opioid-induced respiratory dysfunction if: (a) the patient is at an altitude of about 1000 feet above sea level or greater; or (b) the patient's oxygen saturation level is normal but no greater than about 95%; or (c) the patient received prior dosing with intravenous opioid and is converted to dosing with an oral opioid. The method may further comprise administering opioids to a patient after detecting whether there is an enhanced risk of opioid-induced respiratory dysfunction.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
QRXPHARMA LTDNEW SOUTH WALES AUSTRALIA NEW SOUTH WALES

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Richards, Patricia T West New York, US 4 0
Stern, Warren C Plymouth, US 11 168

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation